Mismatch Profile Influences Outcome After Mechanical Thrombectomy.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 23 12 2020
medline: 20 4 2021
entrez: 22 12 2020
Statut: ppublish

Résumé

Mechanical thrombectomy (MT) is the recommended treatment for acute ischemic stroke caused by anterior circulation large vessel occlusion. However, despite a high rate of reperfusion, the clinical response to successful MT remains highly variable in the early time window where optimal imaging selection criteria have not been established. We hypothesize that the baseline perfusion imaging profile may help forecast the clinical response to MT in this setting. We conducted a prospective multicenter cohort study of patients with large vessel occlusion-related acute ischemic stroke treated by MT within 6 hours. Treatment decisions and the modified Rankin Scale evaluation at 3 months were performed blinded to the results of baseline perfusion imaging. Study groups were defined a posteriori based on predefined imaging profiles: target mismatch (TMM; core volume <70 mL/mismatch ratio >1.2 and mismatch volume >10 mL) versus no TMM or mismatch (MM; mismatch ratio >1.2 and volume >10 mL) versus no MM. Functional recovery (modified Rankin Scale, 0-2) at 3 months was compared based on imaging profile at baseline and whether reperfusion (modified Thrombolysis in Cerebral Infarction 2bc3) was achieved. Two hundred eighteen patients (mean age, 71±15 years; median National Institutes of Health Stroke Scale score, 17 [interquartile range, 12-21]) were enrolled. Perfusion imaging profiles were 71% TMM and 82% MM. The rate of functional recovery was 54% overall. Both TMM and MM profiles were independently associated with a higher rate on functional recovery at 3 months Adjusted odds ratios were 3.3 (95% CI, 1.4-7.9) for TMM and 5.9 (95% CI, 1.8-19.6) for MM. Reperfusion (modified Thrombolysis in Cerebral Infarction 2bc3) was achieved in 86% and was more frequent in TMM and MM patients. Reperfusion was associated with a higher rate of functional recovery in MM and TMM patients but not among those with no MM. In this cohort study, about 80% of the patients with a large vessel occlusion-related acute ischemic stroke had evidence of penumbra, regardless of infarction volume. Perfusion imaging profiles predict the clinical response to MT.

Sections du résumé

BACKGROUND AND PURPOSE
Mechanical thrombectomy (MT) is the recommended treatment for acute ischemic stroke caused by anterior circulation large vessel occlusion. However, despite a high rate of reperfusion, the clinical response to successful MT remains highly variable in the early time window where optimal imaging selection criteria have not been established. We hypothesize that the baseline perfusion imaging profile may help forecast the clinical response to MT in this setting.
METHODS
We conducted a prospective multicenter cohort study of patients with large vessel occlusion-related acute ischemic stroke treated by MT within 6 hours. Treatment decisions and the modified Rankin Scale evaluation at 3 months were performed blinded to the results of baseline perfusion imaging. Study groups were defined a posteriori based on predefined imaging profiles: target mismatch (TMM; core volume <70 mL/mismatch ratio >1.2 and mismatch volume >10 mL) versus no TMM or mismatch (MM; mismatch ratio >1.2 and volume >10 mL) versus no MM. Functional recovery (modified Rankin Scale, 0-2) at 3 months was compared based on imaging profile at baseline and whether reperfusion (modified Thrombolysis in Cerebral Infarction 2bc3) was achieved.
RESULTS
Two hundred eighteen patients (mean age, 71±15 years; median National Institutes of Health Stroke Scale score, 17 [interquartile range, 12-21]) were enrolled. Perfusion imaging profiles were 71% TMM and 82% MM. The rate of functional recovery was 54% overall. Both TMM and MM profiles were independently associated with a higher rate on functional recovery at 3 months Adjusted odds ratios were 3.3 (95% CI, 1.4-7.9) for TMM and 5.9 (95% CI, 1.8-19.6) for MM. Reperfusion (modified Thrombolysis in Cerebral Infarction 2bc3) was achieved in 86% and was more frequent in TMM and MM patients. Reperfusion was associated with a higher rate of functional recovery in MM and TMM patients but not among those with no MM.
CONCLUSIONS
In this cohort study, about 80% of the patients with a large vessel occlusion-related acute ischemic stroke had evidence of penumbra, regardless of infarction volume. Perfusion imaging profiles predict the clinical response to MT.

Identifiants

pubmed: 33349010
doi: 10.1161/STROKEAHA.120.031929
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

232-240

Investigateurs

François Chollet (F)
Marianne Barbieux (M)
Caterina Michelozzi (C)
Philippe Tall (P)
François Caparros (F)
Brigitte Pouzet (B)
Fabienne Calvas (F)
Monique Galitzki (M)
Pauline Renou (P)
François Rouanet (F)
Jerome Berge (J)
Gauthier Marnat (G)
Ludovic Lucas (L)
Cyrielle Coignon (C)
Sharmila Sagnier (S)
Sabrina Debruxelle (S)
Sylvain Ledure (S)

Auteurs

Jean-Marc Olivot (JM)

Acute Stroke Unit (J.-M.O., J.-F.A., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Department of Neuroradiology (A.G., J.D., A.-C.J., F.B., C.C.), Centre Hospitalier Universitaire de Toulouse, France.

Jean-François Albucher (JF)

Acute Stroke Unit (J.-M.O., J.-F.A., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Toulouse Neuro Imaging Center, France (J.-M.O., J.-F.A., A.V., L.C., N.R., F.B.).

Adrien Guenego (A)

Department of Neuroradiology (A.G., J.D., A.-C.J., F.B., C.C.), Centre Hospitalier Universitaire de Toulouse, France.

Claire Thalamas (C)

Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.

Michael Mlynash (M)

Stanford Stroke Center, Stanford University, CA (M. Mlynash, S.C., G.W.A.).

Vanessa Rousseau (V)

Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.

Amel Drif (A)

Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.

Soren Christensen (S)

Stanford Stroke Center, Stanford University, CA (M. Mlynash, S.C., G.W.A.).

Agnes Sommet (A)

Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.

Alain Viguier (A)

Acute Stroke Unit (J.-M.O., J.-F.A., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Toulouse Neuro Imaging Center, France (J.-M.O., J.-F.A., A.V., L.C., N.R., F.B.).

Jean Darcourt (J)

Department of Neuroradiology (A.G., J.D., A.-C.J., F.B., C.C.), Centre Hospitalier Universitaire de Toulouse, France.

Lionel Calvière (L)

Acute Stroke Unit (J.-M.O., J.-F.A., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Toulouse Neuro Imaging Center, France (J.-M.O., J.-F.A., A.V., L.C., N.R., F.B.).

Patrice Menegon (P)

Department of Neuroradiology, Centre Hospitalier Universitaire de Bordeaux, France (P.M., T.T.).

Nicolas Raposo (N)

Acute Stroke Unit (J.-M.O., J.-F.A., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Clinical Investigation Center 1436 (J.-M.O., J.-F.A., C.T., V.R., A.D., A.S., A.V., L.C., N.R.), Centre Hospitalier Universitaire de Toulouse, France.
Toulouse Neuro Imaging Center, France (J.-M.O., J.-F.A., A.V., L.C., N.R., F.B.).

Anne-Christine Januel (AC)

Department of Neuroradiology (A.G., J.D., A.-C.J., F.B., C.C.), Centre Hospitalier Universitaire de Toulouse, France.

Fabrice Bonneville (F)

Department of Neuroradiology (A.G., J.D., A.-C.J., F.B., C.C.), Centre Hospitalier Universitaire de Toulouse, France.
Toulouse Neuro Imaging Center, France (J.-M.O., J.-F.A., A.V., L.C., N.R., F.B.).

Thomas Tourdias (T)

Department of Neuroradiology, Centre Hospitalier Universitaire de Bordeaux, France (P.M., T.T.).

Mikael Mazighi (M)

Université de Paris France, U 1148, A Rothschild Foundation Hospital (M. Mazighi).

Igor Sibon (I)

Centre Hospitalier Universitaire de Bordeaux, Unité Neurovasculaire, Université de Bordeaux, France (I.S.).

Gregory W Albers (GW)

Stanford Stroke Center, Stanford University, CA (M. Mlynash, S.C., G.W.A.).

Christophe Cognard (C)

Department of Neuroradiology (A.G., J.D., A.-C.J., F.B., C.C.), Centre Hospitalier Universitaire de Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH